Ligilactobacillus ruminis

Information

Microbe Identification

Ligilactobacillus ruminis

Microbe id: PMDBM2021576
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Ligilactobacillus ruminis [1623]
Taxonomy Genus: Ligilactobacillus [2767887]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Ligilactobacillus ruminis

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Ligilactobacillus ruminis


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Ligilactobacillus ruminis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Ligilactobacillus ruminis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Ligilactobacillus ruminis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗3.67696735971224mNGS
Hypertension PRJNA509999🔗-3.38237439321288mNGS
Hypertension PRJNA509999🔗-3.23788173795165mNGS
Arthritis, Juvenile PRJNA562467🔗-2.703699996212416S
Diabetes Mellitus, Type 2 PRJDB5860🔗4.4455084235440716S
Liver Cirrhosis, Alcoholic PRJNA690835🔗3.9774517363220916S
Diarrhea PRJEB14038🔗-2.08731363243424mNGS
Colorectal Neoplasms PRJNA936589🔗-3.71071333063335mNGS
Colorectal Neoplasms PRJNA936589🔗-3.51440544376203mNGS
Colorectal Neoplasms PRJEB70916🔗3.64964672532068mNGS
Acne Vulgaris PRJNA449243🔗-2.3469403824543216S
Mental Disorders PRJNA278793🔗2.3951592698732516S
Hepatitis, Autoimmune PRJNA556801🔗3.4745260079131416S
Parkinson Disease PRJNA626004🔗-3.92634724892055mNGS
Parkinson Disease PRJNA588035🔗2.33984621791488mNGS
Colitis, Ulcerative PRJNA993675🔗-2.74625568695595mNGS
Spinal Cord Injuries PRJNA861246🔗2.2308395313923716S
Spinal Cord Injuries PRJNA669472🔗3.5047763275778716S
Hepatitis B, Chronic PRJNA872871🔗3.2038460315127616S
Carcinoma, Hepatocellular PRJNA872871🔗3.2074964899337616S
Carcinoma, Hepatocellular PRJNA932948🔗4.22802235543983mNGS
Celiac Disease PRJNA890948🔗3.9677279204832416S
Caliciviridae Infections PRJNA788674🔗-3.7552779809167816S
Hepatolenticular Degeneration PRJNA1038771🔗3.444912258326416S
Schizophrenia PRJNA1135717🔗3.75087917292005mNGS
Asthma PRJEB23348🔗-2.0098917636441216S
Nervous System Diseases PRJEB41297🔗-4.0604011862091816S
Crohn Disease PRJEB42155🔗-2.8794191422033mNGS
Crohn Disease PRJNA993675🔗-2.78595686415365mNGS
Crohn Disease PRJNA1156939🔗3.0110649135847416S
Crohn Disease PRJNA938107🔗3.8946834496495716S
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗4.6099092607589516S
Cholestasis PRJNA478781🔗4.1171218037489716S
Endometriosis PRJNA715328🔗-4.2219086795353916S
Dermatitis, Atopic PRJEB45443🔗3.38128415781464mNGS
Dermatitis, Atopic PRJEB45443🔗3.49973320564838mNGS
Arthritis, Rheumatoid PRJNA574565🔗-3.3849113312821216S
Arthritis, Rheumatoid PRJNA356102🔗-3.03277729281015mNGS
Anorexia PRJNA674716🔗-2.08815765545836mNGS
Cholangiocarcinoma PRJNA932948🔗3.88144869093821mNGS
Flatulence PRJNA206071🔗-3.0080991516369316S
Neuroblastoma PRJNA716780🔗2.05622650298942mNGS
Graves Ophthalmopathy PRJNA1089481🔗2.283686578842816S
Myasthenia Gravis PRJEB41297🔗-4.0677923856568516S
Irritable Bowel Syndrome PRJEB37924🔗2.95377602686563mNGS
Pancreatic Neoplasms PRJNA665854🔗4.26738610832641mNGS
Atrial Fibrillation PRJNA785409🔗-3.5414853922718816S
Lung Neoplasms PRJNA736821🔗3.229385870584716S
Liver Cirrhosis PRJNA861246🔗2.0988211431065616S
Liver Cirrhosis PRJNA872871🔗3.4968181415686216S
Obesity PRJNA1125836🔗3.05168280936726mNGS
Diabetes Mellitus PRJNA400325🔗3.4361545327241516S
HIV Infections PRJNA810567🔗3.6838763425538816S
Hand, Foot and Mouth Disease PRJNA843173🔗-3.6038493588491816S
Hand, Foot and Mouth Disease PRJNA1017976🔗4.06343585463616S
Renal Insufficiency, Chronic PRJEB65297🔗-3.76756621929779mNGS
Renal Insufficiency, Chronic PRJNA562327🔗3.3001392377914916S
Renal Insufficiency, Chronic PRJNA949558🔗3.5532577757310216S
Breast Neoplasms PRJNA658160🔗-2.7711023430438416S
COVID-19 PRJNA624223🔗4.22666362870588mNGS
COVID-19 PRJNA769052🔗4.2342356095734716S
Sepsis PRJNA641414🔗-2.9191335165569616S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Ligilactobacillus ruminis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Ligilactobacillus ruminis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Ligilactobacillus ruminis

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Ligilactobacillus ruminis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Ligilactobacillus ruminis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Ligilactobacillus ruminis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Ligilactobacillus ruminis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Ligilactobacillus ruminis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Ligilactobacillus ruminis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Ligilactobacillus ruminis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Ligilactobacillus ruminis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?